John U. Que

794 total citations
17 papers, 565 citations indexed

About

John U. Que is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, John U. Que has authored 17 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in John U. Que's work include Pneumonia and Respiratory Infections (4 papers), Vibrio bacteria research studies (4 papers) and Cystic Fibrosis Research Advances (3 papers). John U. Que is often cited by papers focused on Pneumonia and Respiratory Infections (4 papers), Vibrio bacteria research studies (4 papers) and Cystic Fibrosis Research Advances (3 papers). John U. Que collaborates with scholars based in Switzerland, United States and Austria. John U. Que's co-authors include Stanley J. Cryz, Aloïs B. Lang, E Fürer, Urs B. Schaad, Reinhard Glück, A Rüdeberg, Christian Herzog, Alan S. Cross, Beat Althaus and Martin H. Schöni and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Infection and Immunity.

In The Last Decade

John U. Que

17 papers receiving 539 citations

Peers

John U. Que
Guadalupe Cortés Spain
M F Newborg United States
T. Fosse France
C E Fasching United States
M A Edelstein United States
K T Luh Taiwan
Kirsi Gröndahl‐Yli‐Hannuksela Finland
P. H. Lagrange France
S J Sperber United States
Svein Rune Andersen Norway
Guadalupe Cortés Spain
John U. Que
Citations per year, relative to John U. Que John U. Que (= 1×) peers Guadalupe Cortés

Countries citing papers authored by John U. Que

Since Specialization
Citations

This map shows the geographic impact of John U. Que's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John U. Que with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John U. Que more than expected).

Fields of papers citing papers by John U. Que

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John U. Que. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John U. Que. The network helps show where John U. Que may publish in the future.

Co-authorship network of co-authors of John U. Que

This figure shows the co-authorship network connecting the top 25 collaborators of John U. Que. A scholar is included among the top collaborators of John U. Que based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John U. Que. John U. Que is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Zuercher, Adrian W., Michael P. Horn, John U. Que, et al.. (2006). Antibody responses induced by long-term vaccination with an octovalent conjugatePseudomonas aeruginosavaccine in children with cystic fibrosis. FEMS Immunology & Medical Microbiology. 47(2). 302–308. 42 indexed citations
3.
Lang, Aloïs B., A Rüdeberg, Martin H. Schöni, et al.. (2004). Vaccination of Cystic Fibrosis Patients Against Pseudomonas aeruginosa Reduces the Proportion of Patients Infected and Delays Time to Infection. The Pediatric Infectious Disease Journal. 23(6). 504–510. 67 indexed citations
4.
Faucher, Jean‐François, Michel A. Missinou, Pierre‐Blaise Matsiegui, et al.. (2002). Efficacy of Atovaquone/Proguanil for Malaria Prophylaxis in Children and Its Effect on the Immunogenicity of Live Oral Typhoid and Cholera Vaccines. Clinical Infectious Diseases. 35(10). 1147–1154. 34 indexed citations
5.
6.
Cross, Alan S., Steven M. Opal, Apurba K. Bhattacharjee, et al.. (1999). Immunotherapy of sepsis: flawed concept or faulty implementation?. Vaccine. 17. S13–S21. 20 indexed citations
7.
Tsai, Theodore F., Herwig Kollaritsch, John U. Que, et al.. (1999). Compatible Concurrent Administration of Yellow Fever 17D Vaccine with Oral, Live, Attenuated Cholera CVD103‐HgR and Typhoid Ty21a Vaccines. The Journal of Infectious Diseases. 179(2). 522–524. 2 indexed citations
8.
Viret, Jean‐François, Didier Favre, Bernhard Wegmüller, et al.. (1999). Mucosal and Systemic Immune Responses in Humans after Primary and Booster Immunizations with Orally Administered Invasive and Noninvasive Live Attenuated Bacteria. Infection and Immunity. 67(7). 3680–3685. 70 indexed citations
9.
Althaus, Beat, et al.. (1997). Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients. Vaccine. 15(15). 1675–1679. 86 indexed citations
10.
Kollaritsch, Herwig, John U. Que, Christian Künz, et al.. (1997). Safety and Immunogenicity of Live Oral Cholera and Typhoid Vaccines Administered Alone or in Combination with Antimalarial Drugs, Oral Polio Vaccine, or Yellow Fever Vaccine. The Journal of Infectious Diseases. 175(4). 871–875. 42 indexed citations
11.
Cryz, Stanley J., John U. Que, & Reinhard Glück. (1996). A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans. Vaccine. 14(14). 1381–1383. 31 indexed citations
12.
Lang, Aloïs B., Urs B. Schaad, A Rüdeberg, et al.. (1995). Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. The Journal of Pediatrics. 127(5). 711–717. 41 indexed citations
13.
Rubinstein, Arye, Harris Goldstein, Massimo Pettoello‐Mantovani, et al.. (1995). Safety and immunogenicity of a V3 loop synthetic peptide conjugated to purified protein derivative in HIV-seronegative volunteers. AIDS. 9(3). 243–252. 16 indexed citations
14.
Rubinstein, Arye, Harris Goldstein, Massimo Pettoello‐Mantovani, et al.. (1995). Safety and immunogenicity of a V3 loop synthetic peptide conjugated to purified protein derivative in HIV-seronegative volunteers. AIDS. 9(3). 243–252. 18 indexed citations
15.
Edelman, Robert, Steven S. Wasserman, J. Bruce McClain, et al.. (1994). Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously. Vaccine. 12(14). 1288–1294. 58 indexed citations
16.
Cryz, Stanley J., et al.. (1988). Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine. European Journal of Immunology. 18(12). 2073–2075. 22 indexed citations
17.
Que, John U. & Donald E. Woods. (1987). Alteration of Lung Structure and Function by <i>Pseudomonas aeruginos</i><i>a</i>. Pathology and Immunopathology Research. 6(2). 93–102. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guadalupe Cortés Breakdown of academic impact, for papers by M F Newborg Breakdown of academic impact, for papers by T. Fosse Breakdown of academic impact, for papers by C E Fasching Breakdown of academic impact, for papers by M A Edelstein Breakdown of academic impact, for papers by K T Luh Breakdown of academic impact, for papers by Kirsi Gröndahl‐Yli‐Hannuksela Breakdown of academic impact, for papers by P. H. Lagrange Breakdown of academic impact, for papers by S J Sperber Breakdown of academic impact, for papers by Svein Rune Andersen
Rankless by CCL
2026